247 related articles for article (PubMed ID: 597373)
1. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
[TBL] [Abstract][Full Text] [Related]
2. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
3. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
4. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
5. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
Böhm U; Merétey K; Falus A; Bozsóky S
Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
[TBL] [Abstract][Full Text] [Related]
6. [The complement system].
Lambert PH
Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in ulcerative colitis.--II. Correlation with serum protein concentrations and complement conversion products.
Nielsen H; Petersen PH; Svehag SE
Clin Exp Immunol; 1978 Jan; 31(1):81-91. PubMed ID: 639352
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
Sølling J; Sølling K; Jacobsen KU
Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
11. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
12. [Complement system in disseminated lupus erythematosus].
Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA
Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
Shingu M; Todoroki T; Sakai K; Nobunaga M
J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of complement components in pleural fluid: report of 135 cases.
Shitrit D; Ollech JE; Ollech A; Peled N; Amital A; Fox B; Kramer MR
Respir Med; 2008 Nov; 102(11):1631-5. PubMed ID: 18653322
[TBL] [Abstract][Full Text] [Related]
15. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
16. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
17. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
18. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
Adu D; Williams DG
Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
[TBL] [Abstract][Full Text] [Related]
19. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
Valentijn RM; van Es LA; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
[TBL] [Abstract][Full Text] [Related]
20. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
